Thembile Zini

Thembile Zini

Auto-generated profile, based on publicly available information

Thembile Zini

School of Public Health, Faculty of Medicine and Health Sciences, Walter Sisulu University, Private Bag X1, Mthatha 5100, South Africa

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
TZThembile Zini
Thembile Zini
URGENT TSUROURGENT TSURO
URGENT TSURO
LFLINDIWE MODEST FAYE
LINDIWE MODEST FAYE
NSNcomeka Sineke
Ncomeka Sineke
MFMonwabisi Faleni
Monwabisi Faleni
Background: Drug-resistant tuberculosis (DR-TB) remains a major public health challenge in South Africa, particularly in rural settings with high HIV co-infection rates. Understanding predictors of treatment response among people living with HIV is essential for improving clinical management and programmatic outcomes. This study aimed to identify socio-demographic and clinical predictors of treatment outcomes among HIV-positive individuals diagnosed with multidrug-resistant (MDR) and extensively drug-resistant tuberculosis (XDR-TB) in rural Eastern Cape Province, South Africa. Methods: A retrospective cohort study was conducted using routinely collected clinical records of DR-TB patients initiated on treatment between January 2020 and December 2024 at two public healthcare facilities. A total of 239 patients with complete treatment outcome data were included. Treatment outcomes were classified as favourable (cured or treatment completed) or unfavourable (death, treatment failure, or loss to follow-up). Descriptive statistics were used to summarise patient characteristics, while univariate and multivariable logistic regression analyses were performed to identify factors associated with treatment outcomes. Results: Most participants were aged ≤ 39 years (58%), male (60%), unemployed (90%), and without income (80%). MDR-TB accounted for 40% of cases, rifampicin-resistant-TB (RR-TB) for 53%, and XDR-TB for 7.1%. Multivariable analysis showed that XDR-TB was the strongest independent predictor of unfavourable treatment outcome (AOR = 0.18; 95% CI: 0.06–0.58; p = 0.004). Income status was also significantly associated with outcome, with participants reporting some incomes having lower odds of favourable outcomes (AOR = 0.46; 95% CI: 0.23–0.92; p = 0.036). The model demonstrated modest predictive performance (AUC = 0.67). Conclusions: These findings highlight the dominant influence of resistance phenotype, particularly XDR-TB, on treatment prognosis among HIV-positive DR-TB patients in rural Eastern Cape. Integrating early resistance profiling, intensified clinical management of XDR-TB, and socioeconomic support mechanisms may improve treatment outcomes in high-burden rural settings.

8 October 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
TZThembile Zini
Thembile Zini
LFLINDIWE MODEST FAYE
LINDIWE MODEST FAYE
MFMonwabisi Faleni
Monwabisi Faleni
Background: Drug-resistant tuberculosis (DR-TB) remains a major threat to TB control, with success rates below global targets. While clinical determinants such as resistance type are well established, the role of social and behavioral factors is less clearly defined. This study examined both clinical and socioeconomic predictors of DR-TB outcomes in the Eastern Cape, South Africa. Methods: A retrospective cohort analysis was conducted using routinely collected data. Outcomes were collapsed into successful (cured/completed) and unsuccessful (failure, death, loss to follow-up). Descriptive statistics and cross-tabulations compared outcome distributions across demographic, socioeconomic, and clinical variables. Logistic regression estimated adjusted odds ratios (ORs) with 95% confidence intervals (CIs). Random forest modelling assessed predictive performance and ranked feature importance. Results: Cross-tabulations showed significant associations between treatment outcome and gender (p=0.046), income (p=0.0037), and DR-TB type (p=0.0355). Logistic regression confirmed that males had higher odds of success than females (OR=2.11, 95% CI: 1.05–4.21), while salaried patients performed better than those without income (OR=3.46, 95% CI: 0.39–30.96). Pre-XDR TB was associated with reduced odds of success compared to RR-TB (OR=0.25, 95% CI: 0.05–1.19). The logistic model showed modest discrimination (AUC≈0.55). Random forest modelling achieved superior performance and identified age as the most important predictor, followed by patient category, income, social history, education, and DR-TB type. Conclusion: Both clinical and social factors shape DR-TB outcomes. Gender, income, and resistance patterns were consistently influential, while machine-learning analysis highlighted age and socioeconomic determinants. Integrated strategies addressing biomedical and social drivers are essential to improve treatment success in high-burden settings.